{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:26:27Z","timestamp":1794565587721,"version":"4.9.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1097\/01.mph.0000141348.62532.73","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T04:12:02Z","timestamp":1096344722000},"page":"649-655","source":"Crossref","is-referenced-by-count":267,"title":["Platinum Compound-Related Ototoxicity in Children"],"prefix":"10.1097","volume":"26","author":[{"given":"Patrizia","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Lassalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilaine","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Anne","family":"Raquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Izzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadege","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210227","first-page":"353","article-title":"Platinum derivatives in pediatric oncology.","volume":"50","author":"Doz","year":"1993","journal-title":"Arch Fr Pediatr"},{"key":"R3-7-20210227","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.1988.6.1.44","article-title":"Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma.","volume":"6","author":"Hartmann","year":"1988","journal-title":"J Clin Oncol"},{"key":"R4-7-20210227","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/bjc.1990.286","article-title":"Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.","volume":"62","author":"Pinkerton","year":"1990","journal-title":"Br J Cancer"},{"key":"R5-7-20210227","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199513040-00003","article-title":"Comparative adverse effect profiles of platinum drugs.","volume":"13","author":"McKeage","year":"1995","journal-title":"Drug Saf"},{"key":"R6-7-20210227","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002280100319","article-title":"Pharmacokinetics of cisplatin and relation to nephrotoxicity in pediatric patients.","volume":"57","author":"Erdlenbruch","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R7-7-20210227","first-page":"25","article-title":"Carboplatin in pediatrics.","volume":"87","author":"Doz","year":"2000","journal-title":"Bull Cancer"},{"key":"R8-7-20210227","doi-asserted-by":"crossref","first-page":"140S","DOI":"10.1002\/j.1875-9114.1997.tb03816.x","article-title":"Comparative clinical pharmacology of cisplatin and carboplatin.","volume":"17","author":"Murry","year":"1997","journal-title":"Pharmacotherapy"},{"key":"R9-7-20210227","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.1992.10.10.1592","article-title":"Etoposide and carboplatin in neuroblastoma: a French Society of Paediatric Oncology phase II study.","volume":"10","author":"Frappaz","year":"1992","journal-title":"J Clin Oncol"},{"key":"R10-7-20210227","first-page":"64","article-title":"Platinum dose-intensity.","volume":"6","author":"Los","year":"1996","journal-title":"J Infus Chemother"},{"key":"R11-7-20210227","first-page":"1043","article-title":"Melphalan combined with a carboplatin dose based on glomerular filtration rate followed by autologous stem cell rescue for children with solid tumors.","volume":"18","author":"Shaw","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R12-7-20210227","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0959-8049(95)00015-B","article-title":"Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Childrens Cancer Group results.","volume":"31A","author":"Matthay","year":"1995","journal-title":"Eur J Cancer"},{"key":"R13-7-20210227","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.bjc.6690697","article-title":"Dose-related nephrotoxicity of carboplatin in children.","volume":"81","author":"English","year":"1999","journal-title":"Br J Cancer"},{"key":"R14-7-20210227","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1096-911X(199602)26:2<95::AID-MPO5>3.0.CO;2-P","article-title":"Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.","volume":"26","author":"Freilich","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"R15-7-20210227","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.bmt.1701391","article-title":"Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.","volume":"22","author":"Parsons","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R16-7-20210227","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1991.35","article-title":"Ototoxicity of cisplatinum.","volume":"63","author":"Brock","year":"1991","journal-title":"Br J Cancer"},{"key":"R17-7-20210227","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1749-6632.1999.tb08640.x","article-title":"Selective loss of inner hair cells and type-I ganglion neurons in carboplatin-treated chinchillas. Mechanisms of damage and protection.","volume":"884","author":"Ding","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"R18-7-20210227","first-page":"731","article-title":"Temporal bone histopathology of cisplatin ototoxicity.","volume":"16","author":"Hinojosa","year":"1995","journal-title":"Am J Otol"},{"key":"R19-7-20210227","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.1999.tb08633.x","article-title":"Free radicals and hearing. Cause, consequence, and criteria.","volume":"884","author":"Evans","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"R20-7-20210227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/taap.2001.9171","article-title":"Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anions radicals.","volume":"174","author":"Dehne","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"R21-7-20210227","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1200\/JCO.1993.11.12.2314","article-title":"Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Childrens Cancer Study Group.","volume":"11","author":"Newell","year":"1993","journal-title":"J Clin Oncol"},{"key":"R22-7-20210227","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system.","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"R23-7-20210227","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/bjc.1990.208","article-title":"Ototoxicity of cisplatinum in children and adolescents.","volume":"61","author":"Skinner","year":"1990","journal-title":"Br J Cancer"},{"key":"R24-7-20210227","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/sim.4780050610","article-title":"Sensitivity of Fishers exact test to minor perturbations in 2 2 contingency tables.","volume":"5","author":"Dupont","year":"1986","journal-title":"Stat Med"},{"key":"R26-7-20210227","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-3476(83)80551-4","article-title":"Hearing loss in children receiving cisplatin chemotherapy.","volume":"102","author":"McHaney","year":"1983","journal-title":"Pediatrics"},{"key":"R27-7-20210227","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.1989.7.6.754","article-title":"Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.","volume":"7","author":"Schell","year":"1989","journal-title":"J Clin Oncol"},{"key":"R28-7-20210227","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<26::AID-MPO6>3.0.CO;2-W","article-title":"Ototoxicity in children with malignant brain tumors treated with the 8 in 1chemotherapy protocol.","volume":"27","author":"Ilveskoski","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"R29-7-20210227","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mpo.2950170110","article-title":"Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation.","volume":"17","author":"Walker","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"R30-7-20210227","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1288\/00005537-199109000-00010","article-title":"Cis-platinum ototoxicity in children.","volume":"101","author":"Pasic","year":"1991","journal-title":"Laryngoscope"},{"key":"R31-7-20210227","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/00005537-199911000-00016","article-title":"Otologic impact of cisplatin in paediatric oncology patients.","volume":"109","author":"Berg","year":"1999","journal-title":"Laryngoscope"},{"key":"R32-7-20210227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/01050398909070744","article-title":"Hearing identification in difficult to test children. A study of 142 infants and children.","volume":"18","author":"Fjermedal","year":"1989","journal-title":"Scand Audiol"},{"key":"R33-7-20210227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003446-199604000-00003","article-title":"The utility of acoustic reflex thresholds and other conventional audiologic tests for monitoring cisplatin ototoxicity in the pediatric population.","volume":"17","author":"Park","year":"1996","journal-title":"Ear Hear"},{"key":"R34-7-20210227","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.","volume":"77","author":"Bokemeyer","year":"1988","journal-title":"Br J Cancer"},{"key":"R35-7-20210227","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/mpo.2950150105","article-title":"Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.","volume":"15","author":"Dini","year":"1987","journal-title":"Med Pediatr Oncol"},{"key":"R36-7-20210227","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mpo.2950160517","article-title":"Ototoxicity of high-dose cis-platinum in children.","volume":"16","author":"Brock","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"R37-7-20210227","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/mpo.10134","article-title":"Prospective study of carboplatin-based chemotherapy for paediatric germ cell tumors.","volume":"39","author":"Stern","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"R38-7-20210227","first-page":"151","article-title":"Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children.","volume":"23","author":"Macdonald","year":"1944","journal-title":"J Otolaryngol"},{"key":"R39-7-20210227","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/1097-0142(19930615)71:12<4060::AID-CNCR2820711242>3.0.CO;2-0","article-title":"Combined cisplatin and carboplatin.","volume":"15","author":"Waterhouse","year":"1993","journal-title":"Cancer"},{"key":"R40-7-20210227","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.1999.tb00278.x","article-title":"Insights into ototoxicity. Analogies to nephrotoxicity.","volume":"884","author":"Humes","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"R41-7-20210227","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1200\/JCO.1989.7.1.100","article-title":"A pharmacokinetic study of high dose continuous infusion cisplatin in children with solid tumors.","volume":"7","author":"Dominici","year":"1989","journal-title":"J Clin Oncol"},{"key":"R42-7-20210227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/sct.1990.6.145","article-title":"Studies on age-dependent plasma platinum pharmacokinetics and ototoxicity of cisplatin.","volume":"6","author":"Murakami","year":"1990","journal-title":"Semin Cancer Therapy"},{"key":"R43-7-20210227","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0959-8049(97)00341-9","article-title":"Cisplatin pharmacokinetics in children with cancer.","volume":"33","author":"Peng","year":"1997","journal-title":"Eur J Cancer"},{"key":"R44-7-20210227","first-page":"2279","article-title":"The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in paediatric patients: a review.","volume":"14","author":"Peng","year":"1994","journal-title":"Anticancer Res"},{"key":"R45-7-20210227","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00001813-200009000-00007","article-title":"Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.","volume":"11","author":"Peters","year":"2000","journal-title":"Anticancer Drugs"},{"key":"R46-7-20210227","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/00034894021110S502","article-title":"Maturation of human auditory cortex: implications for speech perceptions.","volume":"189","author":"Moore","year":"2002","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"R47-7-20210227","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S0012162201001785","article-title":"Hearing loss in early infancy affects maturation of the auditory pathway.","volume":"44","author":"Tibussek","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"R48-7-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5876(01)00455-4","article-title":"Evoked otoacoustic emissions-an approach for monitoring cisplatin induced ototoxicity in children.","volume":"59","author":"Stavroulaki","year":"2001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R49-7-20210227","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1200\/JCO.2000.18.18.3280","article-title":"Health-related quality of life in survivors of Wilms tumor and advanced neuroblastoma: a cross-sectional study.","volume":"18","author":"Barr","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mph.0000141348.62532.73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:33:08Z","timestamp":1785850388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200410000-00007"}},"subtitle":["Long-Term Follow-Up Reveals Continuous Worsening of Hearing Loss"],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mph.0000141348.62532.73","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}